These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33614491)

  • 1. Mutant p53 as a Regulator and Target of Autophagy.
    Shi Y; Norberg E; Vakifahmetoglu-Norberg H
    Front Oncol; 2020; 10():607149. PubMed ID: 33614491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interplay between mutant p53 proteins and autophagy in cancer cells.
    Cordani M; Butera G; Pacchiana R; Donadelli M
    Biochim Biophys Acta Rev Cancer; 2017 Jan; 1867(1):19-28. PubMed ID: 27871965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting p53 pathways: mechanisms, structures, and advances in therapy.
    Wang H; Guo M; Wei H; Chen Y
    Signal Transduct Target Ther; 2023 Mar; 8(1):92. PubMed ID: 36859359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking mutation independent p53 aggregation by emodin modulates autophagic cell death pathway in lung cancer.
    Haque E; Kamil M; Irfan S; Sheikh S; Hasan A; Nazir A; Mir SS
    Int J Biochem Cell Biol; 2018 Mar; 96():90-95. PubMed ID: 29355754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 in Cancer Progression and Targeted Therapies.
    Zhu G; Pan C; Bei JX; Li B; Liang C; Xu Y; Fu X
    Front Oncol; 2020; 10():595187. PubMed ID: 33240819
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
    Cordani M; Oppici E; Dando I; Butturini E; Dalla Pozza E; Nadal-Serrano M; Oliver J; Roca P; Mariotto S; Cellini B; Blandino G; Palmieri M; Di Agostino S; Donadelli M
    Mol Oncol; 2016 Aug; 10(7):1008-29. PubMed ID: 27118659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Oncogenic Mutant p53 for Cancer Therapy.
    Parrales A; Iwakuma T
    Front Oncol; 2015; 5():288. PubMed ID: 26732534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy.
    Hu W; Chen S; Thorne RF; Wu M
    Adv Exp Med Biol; 2019; 1206():127-149. PubMed ID: 31776983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress.
    Sakitani K; Hirata Y; Hikiba Y; Hayakawa Y; Ihara S; Suzuki H; Suzuki N; Serizawa T; Kinoshita H; Sakamoto K; Nakagawa H; Tateishi K; Maeda S; Ikenoue T; Kawazu S; Koike K
    BMC Cancer; 2015 Oct; 15():795. PubMed ID: 26496833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease.
    Blandino G; Valenti F; Sacconi A; Di Agostino S
    Semin Cell Dev Biol; 2020 Feb; 98():105-117. PubMed ID: 31112799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of
    Monti P; Menichini P; Speciale A; Cutrona G; Fais F; Taiana E; Neri A; Bomben R; Gentile M; Gattei V; Ferrarini M; Morabito F; Fronza G
    Front Oncol; 2020; 10():593383. PubMed ID: 33194757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TP53 fertility network.
    Paskulin Dd; Paixão-Côrtes VR; Hainaut P; Bortolini MC; Ashton-Prolla P
    Genet Mol Biol; 2012 Dec; 35(4 (suppl)):939-46. PubMed ID: 23412905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic Strategies.
    Kaur RP; Vasudeva K; Kumar R; Munshi A
    Curr Pharm Des; 2018; 24(30):3566-3575. PubMed ID: 30255744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
    Garufi A; Pistritto G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
    Blandino G; Di Agostino S
    J Exp Clin Cancer Res; 2018 Feb; 37(1):30. PubMed ID: 29448954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A degradative detour for mutant TP53.
    Vakifahmetoglu-Norberg H; Yuan J
    Autophagy; 2013 Dec; 9(12):2158-60. PubMed ID: 24145670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR129-1 regulates protein phosphatase 1D protein expression under hypoxic conditions in non-small cell lung cancer cells harboring a TP53 mutation.
    Yin HL; Xu HW; Lin QY
    Oncol Lett; 2020 Sep; 20(3):2239-2247. PubMed ID: 32782541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I; Cordani M; Donadelli M
    IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway.
    Fröhlich LF; Mrakovcic M; Smole C; Zatloukal K
    Cancer Cell Int; 2016; 16(1):68. PubMed ID: 27601937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53
    Monti P; Ravera S; Speciale A; Velkova I; Foggetti G; Degan P; Fronza G; Menichini P
    Front Genet; 2022; 13():974662. PubMed ID: 36226181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.